TMEM16A对抗性:治疗潜力与喘中β-对抗剂反应无敏化的治疗潜力
Amy Wu1, Aisha Kuforiji1, Yi Zhang1
1Department of Anesthesiology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
American journal of respiratory cell and molecular biology
|November 19, 2024
概括
阻止激活化通道跨膜成员16A (TMEM16A) 放松呼吸道光滑肌肉,即使β-上腺受体反应能力降低. TMEM16A对抗性为喘管理提供了一个新的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 离子通道生物学 离子通道生物学
背景情况:
- 在喘中β-激素剂的疗效受到β-腺素受体脱敏的限制,导致持续的支气管收缩.
- 需要新的治疗点来克服β - 激动剂分泌不良并改善喘控制.
- 跨膜成员16A (TMEM16A) 抗已经显示出呼吸道平滑肌肉放松的潜力.
研究的目的:
- 为了评估TMEM16A对抗在β-agonist-desensitized气道光滑肌肉 (ASM) 的疗效.
- 研究TMEM16A对抗作用在维护β-上腺体受体响应的作用.
- 探索TMEM16A对抗性作为控制喘症状的治疗策略.
主要方法:
- 电线肌图和精确切割的小鼠肺部切片被用于评估ASM收缩性.
- 研究包括与或没有先前的β-腺素受体脱敏和TMEM16A抗的β-激素治疗.
- 人类ASM细胞和组织被用于测量TMEM16A对抗作用对β2-上腺受体介导的cAMP合成和收缩性.
主要成果:
- 急性TMEM16A抗作用有效地放松了小鼠和人类呼吸道中的ASM,即使对β-agonists无敏化.
- 慢性TMEM16A抗剂预治疗防止了上呼吸道β-抗剂反应的功能脱敏化.
- TMEM16A对抗性阻止了人类ASM细胞中β-激动剂诱导的cAMP生产的脱敏化.
结论:
- TMEM16A对抗性表明对ASM放松具有有利的治疗特征,克服β-激动剂脱敏.
- 这一途径代表了喘潜在的新型治疗方法,特别是在存在β-腺受体分泌时.
- 向TMEM16A可能提供一种新的策略来管理耐火性支气管收缩并改善喘症状控制.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:20Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
01:30Adrenergic Agonists: Therapeutic Uses
731
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
731
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
244
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
244
01:19Antiasthma Drugs: Leukotriene Modifiers
245
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
245